_1777370220974_847775619.png&w=48&q=75){kind=small}
_1777370193195_831968492.png&w=48&q=75){kind=small}
Revolution Medicines wins FDA approval for pancreatic cancer drug
The U.S. Food and Drug Administration approved Revolution Medicines’ targeted drug for adults with metastatic pancreatic cancer who have received previous treatment or cannot tolerate combination chemotherapy.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)